| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/03/2002 | US20020001588 Coupling drugs to an antibody (polyclonal) or fragment or derivative that recognizes a substance (antigen) unique to an organ; antitumor agents for treatment of adenocarcinoma, benign prostatic hypertrophy, and prostatitis |
| 01/03/2002 | US20020001587 Tyrosine kinases; cell differentiation; epidermal growth factor receptor; antitumor agents |
| 01/03/2002 | US20020001570 Use of sunscreen combinations comprising, as essential constituent, amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations |
| 01/03/2002 | US20020001567 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 01/03/2002 | DE10031044A1 Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere Endoparasiticides means of voluntary oral ingestion by animals |
| 01/03/2002 | DE10030891A1 New 3,4-dihydroxybenzyl-substituted carbonic acid derivatives are antioxidants and radical scavengers useful e.g. for preventing skin aging or protecting cosmetic, dermatological or foodstuff compositions against oxidation |
| 01/03/2002 | DE10029462A1 New water soluble polymers based on macromonomer with polyalkylene oxide units, useful as adjuvants in cosmetic, pharmaceutical and agrochemical compositions |
| 01/03/2002 | CA2415236A1 Novispirins: antimicrobial peptides |
| 01/03/2002 | CA2414401A1 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 01/03/2002 | CA2414150A1 Modified forms of nonsteroidal anti-inflammatory drugs and uses thereof |
| 01/03/2002 | CA2413816A1 Controlled release arginine formulations |
| 01/03/2002 | CA2413545A1 Methods and compositions for treating pain of the mucous membrane |
| 01/03/2002 | CA2413354A1 Neurotoxic a.beta. oligomers in alzheimer's disease |
| 01/03/2002 | CA2413338A1 Protein mixtures for wound healing |
| 01/03/2002 | CA2413330A1 Wet milling process |
| 01/03/2002 | CA2413201A1 Treatment for cardiovascular disease |
| 01/03/2002 | CA2413157A1 Biodegradable vehicles and delivery systems of biologically active substances |
| 01/03/2002 | CA2412582A1 Dds compound and process for the preparation thereof |
| 01/03/2002 | CA2412490A1 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
| 01/03/2002 | CA2412256A1 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | CA2412024A1 Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| 01/03/2002 | CA2412017A1 Multiple stimulus reversible hydrogels |
| 01/03/2002 | CA2411545A1 Tripeptide prodrug compounds |
| 01/03/2002 | CA2411167A1 Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use |
| 01/02/2002 | WO2002098412A1 Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester |
| 01/02/2002 | EP1167972A2 Enzyme catalyzed therapeutic agents |
| 01/02/2002 | EP1167383A1 Novel conjugates of opioids and endogenous carriers |
| 01/02/2002 | EP1167379A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167378A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167377A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1166801A1 Preparations containing silicon dioxide to improve the taste thereof |
| 01/02/2002 | EP1166800A1 Pharmaceutical compositions containing antibiotics and fructan mixtures |
| 01/02/2002 | EP1166796A2 Agents for preventing and treating thrombocytopenia |
| 01/02/2002 | EP1166788A1 Remedies for joint diseases |
| 01/02/2002 | EP1166779A2 The use of nimesulide in the treatment of dermatological diseases |
| 01/02/2002 | EP1166777A1 Taste masked pharmaceutical particles |
| 01/02/2002 | EP1166776A2 Process of preparation of solid oral dosage forms with delayed release |
| 01/02/2002 | EP1166773A1 Solution of N- O(p-pivaloyloxbenzenesulfonylamino)benzoyl glycine monosodium salt tetra-hydrate and drug product thereof |
| 01/02/2002 | EP1166771A1 Invers autoinversible latices based on fatty acid esters and cosmetic, dermocosmetic, dermopharmaceutic or pharmaceutic compositions |
| 01/02/2002 | EP1166769A1 Lipid composition containing a liquid crystal structure |
| 01/02/2002 | EP1166653A2 Iron-containing protein composition |
| 01/02/2002 | EP1166651A1 Synthetic sweetener |
| 01/02/2002 | EP1165819A2 Delivery of functional protein sequences by translocating polypeptides |
| 01/02/2002 | EP1165754A1 Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof |
| 01/02/2002 | EP1165620A1 INCLUSION COMPLEXES OF POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES WITH $g(g)-CYCLODEXTRIN |
| 01/02/2002 | EP1165612A2 A method for purifying human growth hormone |
| 01/02/2002 | EP1165597A1 Bifunctional molecules for delivery of therapeutics |
| 01/02/2002 | EP1165541A1 Dimeric compounds and as inhibitors of neuraminidase |
| 01/02/2002 | EP1165493A1 Nitrogen mustard compounds and prodrugs therefor |
| 01/02/2002 | EP1165487A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 01/02/2002 | EP1165142A2 Lipid-based artificial particles inducing cell-mediated immunity |
| 01/02/2002 | EP1165141A2 Novel formulations comprising lipid-regulating agents |
| 01/02/2002 | EP1165137A1 Sphingomyelin containing preparation for the enhancement of tumor therapy |
| 01/02/2002 | EP1165134A1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 01/02/2002 | EP1165126A1 Human papillomavirus vaccine with disassembled and reassembled virus-like particles |
| 01/02/2002 | EP1165122A2 Use of molecular weight-amplified hirudin as an anticoagulant in extracorporeal renal replacement therapy |
| 01/02/2002 | EP1165119A1 Composition based on oppositely-charged polypeptides |
| 01/02/2002 | EP1165114A1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 01/02/2002 | EP1165100A2 Methods of treating schizophrenia |
| 01/02/2002 | EP1165097A2 A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| 01/02/2002 | EP1165091A1 Pharmaceutical emulsions for retroviral protease inhibitors |
| 01/02/2002 | EP1165081A1 Tolperison-containing, pharmaceutical preparation for oral administration |
| 01/02/2002 | EP1165077A2 Viral treatment |
| 01/02/2002 | EP1165074A2 Viral treatment |
| 01/02/2002 | EP1165072A2 Valdecoxib compositions |
| 01/02/2002 | EP1165070A1 Thiadiazolyl urea or thiourea derivatitives for antiviral treatment |
| 01/02/2002 | EP1165058A2 Use of azalide antibiotics for the topical treatment or prevention of ocular infections |
| 01/02/2002 | EP1165055A2 Pharmaceutical composition containing an extrusion additive |
| 01/02/2002 | EP1165054A1 Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
| 01/02/2002 | EP1165053A1 Fast-dispersing dosage forms containing fish gelatin |
| 01/02/2002 | EP1165050A1 Methods for fine powder formation |
| 01/02/2002 | EP1165048A1 Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| 01/02/2002 | EP1165047A1 Fusogenic lipids and vesicles |
| 01/02/2002 | EP1165046A1 Propofol compositions containing preservative additives |
| 01/02/2002 | EP1165045A1 Propofol formulation with enhanced microbial characteristics |
| 01/02/2002 | EP1165044A2 High potency dihydroergotamine compositions |
| 01/02/2002 | EP1165041A1 Antimicrobial wipes which provide improved immediate germ reduction |
| 01/02/2002 | EP1165037A1 USE OF NANOSCALAR WATER-SOLUBLE $g(b)-(1,3) GLUCANS |
| 01/02/2002 | EP1164996A1 Transdermal therapeutic system with nicotine and addition of monoterpene ketones |
| 01/02/2002 | EP1164991A1 Gels formed by the interaction of poly(aldehyde) with various substances |
| 01/02/2002 | EP1164846A1 Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension |
| 01/02/2002 | EP1051157B1 Controlled release delivery of peptide or protein |
| 01/02/2002 | EP1005372B1 Anti-cd40l immunotoxins for the treatment of diseases |
| 01/02/2002 | EP0934342B1 Composition containing chitosan |
| 01/02/2002 | EP0600079B1 Oral 1alpha-hydroxyprevitamin d |
| 01/02/2002 | CN1329597A Pyridinium derivatives for treatment of diabetic and aging-related vascular complications |
| 01/02/2002 | CN1329508A Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 01/02/2002 | CN1329507A Topical compositions comprising ascomycins |
| 01/02/2002 | CN1329504A F1t4(VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 01/02/2002 | CN1329502A Pharmaceutical compositions containing insulin |
| 01/02/2002 | CN1329496A Methods and cmpositions for prevention of tolerance to medications |
| 01/02/2002 | CN1329494A Micronized eplerenone compositions |
| 01/02/2002 | CN1329488A Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| 01/02/2002 | CN1329487A Dispersible compositions containing L-dopaethyl ester |
| 01/02/2002 | CN1329485A Compositions containing a peptide and polylactic-glycolic acid suitable for preparing subcutaneous implants with an extended release period |
| 01/02/2002 | CN1329478A Capsules |
| 01/02/2002 | CN1328811A Method for producing solid oral preparation form with continuous released active components |
| 01/02/2002 | CN1076972C Base agent and drug composition thereof which are taken through skin |
| 01/01/2002 | US6335463 Copper catalyzed arylation of 2,5-dichlorobenzoic acid with n-(4-fluorophenyl)glycine in which alkali metal salts are employed in aqueous alkaline environment |
| 01/01/2002 | US6335457 Complex containing biologically assimilable orthosilicic acid, which is under solid form, stable and concentrated, and a process for preparation of said complex |